Zebrafish as a model for investigating developmental lead (Pb) neurotoxicity as a risk factor in adult neurodegenerative disease: A mini-review

NeuroToxicology

Volumn 43, Issue , 2014, Pages 57-64

  Lee, Jinyoung ^a   Freeman, Jennifer L ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Lead; Neurodegenerative disease; Parkinson's disease; Zebrafish

Indexed keywords

LEAD; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ADULT; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL GENETICS; ARTICLE; BEHAVIOR CHANGE; BRAIN DEVELOPMENT; DEGENERATIVE DISEASE; DEVELOPMENTAL GENE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EXPERIMENTAL MODEL; GENE FUNCTION; GENE IDENTIFICATION; GENOME ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN GENOME; MOLECULAR PATHOLOGY; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ZEBRA FISH; ANIMAL; COMPLICATION; DISEASE MODEL; LEAD POISONING; NEURODEGENERATIVE DISEASES; ANIMAL MODEL; CENTRAL NERVOUS SYSTEM; MUTATIONAL ANALYSIS; NEUROPATHOLOGY; OCCUPATIONAL EXPOSURE; PROTEIN EXPRESSION;

ANIMALIA; DANIO RERIO; VERTEBRATA;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LEAD; LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD; NEURODEGENERATIVE DISEASES; ZEBRAFISH;

EID: 84905923814     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.03.008     Document Type: Article

References (102)

1. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimer Dement 2013, 9:208-245.
2. Bai Q., Garver J.A., Hukriede N.A., Burton E.A. Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene. Nucleic Acids Res 2007, 35:6501-6516.
3. Bai Q., Mullett S.J., Garver J.A., Hinkle D.A., Burton E.A. Zebrafish DJ-1 is evolutionarily conserved and expressed in dopaminergic neurons. Brain Res 2006, 1113:33-44.
4. Bakulski K.M., Rozek L.S., Dolinoy D.C., Paulson H.L., Hu H. Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics. Curr Alzheimer Res 2012, 9:563-573.
5. Bandmann O., Burton E.A. Genetic zebrafish models of neurodegenerative diseases. Neurobiol Dis 2010, 40:58-65.
6. Barker D.J. The fetal and infant origins of adult disease. BMJ 1990, 301:1111.
7. Barker D.J. The developmental origins of adult disease. J Am Coll Nutr 2004, 23:588S-595S.
8. Barker D.J., Hales C.N., Fall C.H., Osmond C., Phipps K., Clark P.M. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993, 36:62-67.
9. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-414.
10. Basha M.R., Wei W., Bakheet S.A., Benitez N., Siddiqi H.K., Ge Y.W., et al. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J Neurosci 2005, 25:823-829.
11. Bellinger D., Leviton A., Waternaux C., Needleman H., Rabinowitz M. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 1987, 316:1037-1043.
12. Bihaqi S.W., Bahmani A., Subaiea G.M., Zawia N.H. Infantile exposure to lead and late-age cognitive decline: relevance to AD. Alzheimer Dement 2013, pii:S1552-5260(13)00131-3.
13. Bihaqi S.W., Huang H., Wu J., Zawia N.H. Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: implications for Alzheimer's disease. J Alzheimers Dis 2011, 27:819-833.
14. Bihaqi S.W., Zawia N.H. Alzheimer's disease biomarkers and epigenetic intermediates following exposure to Pb in vitro. Curr Alzheimer Res 2012, 9:555-562.
15. Bird T.D. Early-onset familial Alzheimer disease. Gene reviews 2012, University of Washington, Seattle, Seattle, WA. R.A. Pagon, M.P. Adam, T.D. Bird, C.R. Dolan, C.T. Fong, R.J.H. Smith (Eds.).
16. Bolin C.M., Basha R., Cox D., Zawia N.H., Maloney B., Lahiri D.K., et al. Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. FASEB 2006, 20:788-790.
17. Braun J.M., Kahn R.S., Froehlich T., Auinger P., Lanphear B.P. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect 2006, 114:1904-1909.
18. Brown R.C., Lockwood A.H., Sonawane B.R. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 2005, 113:1250-1256.
19. Buske C., Gerlai R. Early embryonic ethanol exposure impairs shoaling and the dopaminergic and serotoninergic systems in adult zebrafish. Neurotoxicol Teratol 2011, 33:698-707.
20. Canfield R.L., Henderson C.R., Cory-Slechta D.A., Cox C., Jusko T.A., Lanphear B.P. Intellectual impairment in children with blood lead concentrations below 10microg per deciliter. N Engl J Med 2003, 348:1517-1526.
21. Carvan M.J., Loucks E., Weber D.N., Williams F.E. Ethanol effects on the developing zebrafish: neurobehavior and skeletal morphogenesis. Neurotoxicol Teratol 2004, 26:757-768.
22. CDC CDC response to advisory committee on childhood lead poisoning prevention recommendations. Low level lead exposure harms children: a renewed call for primary prevention 2012, U.S. Centers for Disease Control and Prevention, Atlanta, GA, [updated 07.06.12].
23. CDC Low level lead exposure harms children: a renewed call for primary prevention 2012, Advisory Committee on Childhood Lead Poisoning Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, [04.01.12].
24. CDC Preventing lead poisoning in young children. A statement by the Centers for Disease Control 1991, US Department of Health and Human Services, [October 1991].
25. Chen J., Chen Y., Liu W., Bai C., Liu X., Liu K., et al. Developmental lead acetate exposure induces embryonic toxicity and memory deficit in adult zebrafish. Neurotoxicol Teratol 2012, 34:581-586.
26. Coon S., Stark A., Peterson E., Gloi A., Kortsha G., Pounds J., et al. Whole-body lifetime occupational lead exposure and risk of Parkinson's disease. Environ Health Perspect 2006, 114:1872-1876.
27. Damier P., Hirsch E.C., Agid Y., Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999, 122:1437-1448.
28. Dietrich K.N., Krafft K.M., Bornschein R.L., Hammond P.B., Berger O., Succop P.A., et al. Low-level fetal lead exposure effect on neurobehavioral development in early infancy. Pediatrics 1987, 80:721-730.
29. Dorsey C.D., Lee B.K., Bolla K.I., Weaver V.M., Lee S.S., Lee G.S., et al. Comparison of patella lead with blood lead and tibia lead and their associations with neurobehavioral test scores. J Occup Environ Med 2006, 48:489-496.
30. Dosunmu R., Alashwal H., Zawia N.H. Genome-wide expression and methylation profiling in the aged rodent brain due to early-life Pb exposure and its relevance to aging. Mech Ageing Dev 2012, 133:435-443.
31. Dou C., Zhang J. Effects of lead on neurogenesis during zebrafish embryonic brain development. J Hazard Mater 2011, 194:277-282.
32. Eddins D., Cerutti D., Williams P., Linney E., Levin E.D. Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. Neurotoxicol Teratol 2010, 32:99-108.
33. Fernandes Y., Gerlai R. Long-term behavioral changes in response to early developmental exposure to ethanol in zebrafish. Alcohol Clin Exp Res 2009, 33:601-609.
34. Fett M.E., Pilsl A., Paquet D., van Bebber F., Haass C., Tatzelt J., et al. Parkin is protective against proteotoxic stress in a transgenic zebrafish model. PLoS ONE 2010, 5:e11783.
35. Gasser T. Update on the genetics of Parkinson's disease. Mov Disord 2007, 22(Suppl. 17):S343-S350.
36. Gerhard G.S., Kauffman E.J., Wang X., Stewart R., Moore J.L., Kasales C.J., et al. Life spans and senescent phenotypes in two strains of Zebrafish (Danio rerio). Exp Gerontol 2002, 37:1055-1068.
37. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., Brown G.G., et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997, 48:650-658.
38. Groth C., Nornes S., McCarty R., Tamme R., Lardelli M. Identification of a second presenilin gene in zebrafish with similarity to the human Alzheimer's disease gene presenilin2. Dev Genes Evol 2002, 212:486-490.
39. Gu H., Robison G., Hong L., Barrea R., Wei X., Farlow M.R., et al. Increased beta-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure. Toxiol Lett 2012, 213:211-219.
40. Gu H., Wei X., Monnot A.D., Fontanilla C.V., Behl M., Farlow M.R., et al. Lead exposure increases levels of beta-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice. Neurosci Lett 2011, 490:16-20.
41. Han W.Y., Zhao F.J., Shi Y.Z., Ma L.F., Ruan J.Y. Scale and causes of lead contamination in Chinese tea. Environ Pollut 2006, 139:125-132.
42. Hebert L.E., Weuve J., Scherr P.A., Evans D.A. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013, 80:1778-1783.
43. Howe K., Clark M.D., Torroja C.F., Torrance J., Berthelot C., Muffato M., et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013, 496:498-550.
44. Huang H., Bihaqi S.W., Cui L., Zawia N.H. In vitro Pb exposure disturbs the balance between Abeta production and elimination: the role of AbetaPP and neprilysin. Neurotoxicology 2011, 32:300-306.
45. Kabashi E., Brustein E., Champagne N., Drapeau P. Zebrafish models for the functional genomics of neurogenetic disorders. Biochim Biophys Acta 2011, 1812:335-345.
46. Kawahara M., Kato-Negishi M. Link between aluminum and the pathogenesis of Alzheimer's Disease: The integration of the aluminum and amyloid cascade hypotheses. Int J Alzheimers Dis 2011, 2011:276393.
47. Khor Y.M., Soga T., Parhar I.S. Caffeine neuroprotects against dexamethasone-induced anxiety-like behaviour in the Zebrafish (Danio rerio). Gen Comp Endocrinol 2013, 181:310-315.
48. Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., Schilling T.F. Stages of embryonic development of the zebrafish. Dev Dyn 1995, 203:253-310.
49. Klein C., Westenberger A. Genetics of Parkinson's disease. Cold Spring Harb Perspect Med 2012, 2:a880088.
50. Kozlowski H., Luczkowski M., Remelli M., Valensin D. Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases). Coordinat Chem Rev 2012, 256:2129-2141.
51. Lee Y., Kim Y.H., Yun J.S., Lee C.J. Valproic acid decreases the proliferation of telencephalic cells in zebrafish larvae. Neurotoxicol Teratol 2013, 39:91-99.
52. Leimer U., Lun K., Romig H., Walter J., Grunberg J., Brand M., et al. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Biochemistry 1999, 38:13602-13609.
53. Levin E.D., Chrysanthis E., Yacisin K., Linney E. Chlorpyrifos exposure of developing zebrafish: effects on survival and long-term effects on response latency and spatial discrimination. Neurotoxicol Teratol 2003, 25:51-57.
54. Levin E.D., Sledge D., Roach S., Petro A., Donerly S., Linney E. Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish. Neurotoxicol Teratol 2011, 33:668-673.
55. Lucking C.B., Durr A., Bonifati V., Vaughan J., De Michele G., Gasser T., et al. Association between early-onset Parkinson's disease and mutations in the Parkin gene. N Engl J Med 2000, 342:1560-1567.
56. Mahley R.W., Weisgraber K.H., Huang Y., Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 2009, 50(Suppl.):S183-S188.
57. Mazumdar M., Xia W., Hofmann O., Gregas M., Sui S.H., Hide W., et al. Prenatal lead levels, plasma amyloid beta levels, and gene expression in young adulthood. Environ Health Perspect 2012, 120:702-707.
58. Munoz D.G., Feldman H. Causes of Alzheimer's disease. CMAJ 2000, 162:65-72.
59. Muntner P., Menke A., DeSalvo K.B., Rabito F.A., Batuman V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Int Med 2005, 165:2155-2161.
60. Musa A., Lehrach H., Russo V.A. Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development. Dev Genes Evol 2001, 211:563-567.
61. Nabulo G., Oryem-Origa H., Diamond M. Assessment of lead, cadmium, and zinc contamination of roadside soils, surface films, and vegetables in Kampala City, Uganda. Environ Res 2006, 101:42-52.
62. Nuytemans K., Theuns J., Cruts M., Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 2010, 31:763-780.
63. Paquet D., Bhat R., Sydow A., Mandelkow E.M., Berg S., Hellberg S., et al. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J Clin Invest 2009, 119:1382-1395.
64. Peterson S.M., Zhang J., Freeman J.L. Developmental reelin expression and time point-specific alterations from lead exposure in zebrafish. Neurotoxicol Teratol 2013, 38:53-60.
65. Peterson S.M., Zhang J., Weber G., Freeman J.L. Global gene expression analysis reveals dynamic and developmental stage-dependent enrichment of lead-induced neurological gene alterations. Environ Health Perspect 2011, 119:615-621.
66. Pirkle J.L., Brody D.J., Gunter E.W., Kramer R.A., Paschal D.C., Flegal K.M., et al. The decline in blood lead levels in the United States The National Health and Nutrition Examination Surveys (NHANES). JAMA 1994, 272:284-291.
67. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S., Apolipoprotein E. polymorphism and Alzheimer's disease. Lancet 1993, 342:697-699.
68. Powers C.M., Levin E.D., Seidler F.J., Slotkin T.A. Silver exposure in developing zebrafish produces persistent synaptic and behavioral changes. Neurotoxicol Teratol 2011, 33:329-332.
69. Rajarao S.J., Canfield V.A., Mohideen M.A., Yan Y.L., Postlethwait J.H., Cheng K.C., et al. The repertoire of Na,K-ATPase alpha and beta subunit genes expressed in the zebrafish, Danio rerio. Genome Res 2001, 11:1211-1220.
70. Rankin C.W., Nriagu J.O., Aggarwal J.K., Arowolo T.A., Adebayo K., Flegal A.R. Lead contamination in cocoa and cocoa products: isotopic evidence of global contamination. Environ Health Perspect 2005, 113:1344-1348.
71. Raslan A.A., Kee Y. Tackling neurodegenerative diseases: animal models of Alzheimer's disease and Parkinson's disease. Genes Genom 2013, 1-16.
72. Reed B., Jennings M. Guidance on the housing and care of zebrafish (Danio rerio) 2010, 12. RSPCA Research Animals Department, West Sussex.
73. Rice C., Ghorai J.K., Zalewski K., Weber D.N. Developmental lead exposure causes startle response deficits in zebrafish. Aquat Toxicol 2011, 105:600-608.
74. Sager J.J., Bai Q., Burton E.A. Transgenic zebrafish models of neurodegenerative diseases. Brain Struct Funct 2010, 214:285-302.
75. Saili K.S., Corvi M.M., Weber D.N., Patel A.U., Das S.R., Przybyla J., et al. Neurodevelopmental low-dose bisphenol A exposure leads to early life-stage hyperactivity and learning deficits in adult zebrafish. Toxicology 2012, 291:83-92.
76. Sallinen V., Kolehmainen J., Priyadarshini M., Toleikyte G., Chen Y.C., Panula P. Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish. Neurobiol Dis 2010, 40:93-101.
77. Schwartz B.S., Lee B.K., Bandeen-Roche K., Stewart W., Bolla K., Links J., et al. Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology 2005, 16:106-113.
78. Serrano-Pozo A., Frosch M.P., Masliah E., Hyman B.T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011, 1:a890061.
79. Sheng D., Qu D., Kwok K.H., Ng S.S., Lim A.Y., Aw S.S., et al. Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defect. PLoS Genet 2010, 6:e1000914.
80. Sledge D., Yen J., Morton T., Dishaw L., Petro A., Donerly S., et al. Critical duration of exposure for developmental chlorpyrifos-induced neurobehavioral toxicity. Neurotoxicol Teratol 2011, 33:742-751.
81. Smith L.E., Carvan M.J., Dellinger J.A., Ghorai J.K., White D.B., Williams F.E., et al. Developmental selenomethionine and methylmercury exposures affect zebrafish learning. Neurotoxicol Teratol 2010, 32:246-255.
82. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993, 90:1977-1981.
83. Surkan P.J., Zhang A., Trachtenberg F., Daniel D.B., McKinlay S., Bellinger D.C. Neuropsychological function in children with blood lead levels<10 microg/dL. Neurotoxicology 2007, 28:1170-1177.
84. Takaoka M., Yoshinaga J., Tanaka A. Influence of paint chips on lead concentration in the soil of public playgrounds in Tokyo. J Environ Monit 2006, 8:393-398.
85. Tomasiewicz H.G., Flaherty D.B., Soria J.P., Wood J.G. Transgenic zebrafish model of neurodegeneration. J Neurosci Res 2002, 70:734-745.
86. Tong S., von Schirnding Y.E., Prapamontol T. Environmental lead exposure: a public health problem of global dimensions. Bull World Health Org 2000, 78:1068-1077.
87. Truong L., Saili K.S., Miller J.M., Hutchison J.E., Tanguay R.L. Persistent adult zebrafish behavioral deficits results from acute embryonic exposure to gold nanoparticles. Comp Biochem Physiol C Toxicol Pharmacol 2012, 155:269-274.
88. Turner A., Sogo Y.S. Concentrations and bioaccessibilities of metals in exterior urban paints. Chemosphere 2012, 86:614-618.
89. Uversky V.N., Li J., Fink A.L. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem 2001, 276:44284-44296.
90. van Bebber F., Hruscha A., Willem M., Schmid B., Haass C. Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes. J Neurochem 2013, 127:471-481.
91. Weber D.N., Connaughton V.P., Dellinger J.A., Klemer D., Udvadia A., Carvan M.J. Selenomethionine reduces visual deficits due to developmental methylmercury exposures. Physiol Behav 2008, 93:250-260.
92. Weber D.N., Ghorai J.K. Experimental design affects social behavior outcomes in adult zebrafish developmentally exposed to lead. Zebrafish 2013, 10:294-302.
93. Weinberger M., Dostrovsky J.O. A basis for the pathological oscillations in basal ganglia: the crucial role of dopamine. Neuroreport 2011, 22:151-156.
94. Willis A.W., Evanoff B.A., Lian M., Criswell S.R., Racette B.A. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare Beneficiaries. Neuroepidemiology 2010, 34:143.
95. Wright N.J., Thacher T.D., Pfitzner M.A., Fischer P.R., Pettifor J.M. Causes of lead toxicity in a Nigerian city. Arch Dis Child 2005, 90:262-266.
96. Wu J., Basha M.R., Brock B., Cox D.P., Cardozo-Pelaez F., McPherson C.A., et al. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J Neurosci 2008, 28:3-9.
97. Xi Y., Noble S., Ekker M. Modeling neurodegeneration in zebrafish. Curr Neurol Neurosci Rep 2011, 11:274-282.
98. Yamamoto A., Shin R.W., Hasegawa K., Naiki H., Sato H., Yoshimasu F., et al. Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J Neurochem 2002, 82:1137-1147.
99. ZFIN Staff Curation of orthology data. Manually curated data 2003, Available from: http://zfin.org/.
100. Zhang J., Peterson S.M., Weber G.J., Zhu X., Zheng W., Freeman J.L. Decreased axonal density and altered expression profiles of axonal guidance genes underlying lead (Pb) neurodevelopmental toxicity at early embryonic stages in the zebrafish. Neurotoxicol Teratol 2011, 33:715-720.
101. Zhang S., Zhang M., Cai F., Song W. Biological function of Presenilin and its role in AD pathogenesis. Transl Neurodegen 2013, 2:15.
102. Zhang Z.X., Roman G.C. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993, 12:195-208.